Sarbanes, Pappas Highlight Efforts to Fight Big Pharma and Lower Prescription Drug Prices for the American People

FOR IMMEDIATE RELEASE

Aug 22, 2019
Contact: Daniel Jacobs
(202) 225-4016

EXETER, N.H. – Democracy Reform Task Force Chair Rep. John Sarbanes (D-Md.) and Congressman Chris Pappas (D-N.H.) today held a roundtable discussion with President of End Citizens United Action Fund Tiffany Muller and local stakeholders in New Hampshire to discuss how reducing the influence of money in politics can help curb the skyrocketing costs of prescription drugs.

H.R. 1, a sweeping democracy reform package authored by Congressman Sarbanes and co-sponsored by Congressman Pappas, would reduce the corrosive influence of Big Pharma in Washington. The bill passed the U.S. House of Representatives in March. Majority Leader Mitch McConnell (R-Ky.) continues to block the bill in the U.S. Senate.

“For far too long, the pharmaceutical industry has held Washington in a vice grip, using its army of lobbyists and its large campaign contributions to ensure that Congress does its bidding – all at the expense of the American people, who are saddled with soaring prescription drug prices,” said Congressman Sarbanes, Chair of the Democracy Reform Task Force and author of H.R. 1, House Democrats’ once-in-a-generation reform bill to clean up corruption in Washington. “To lower prescription drug prices and reduce the cost of health care for the American people, we must reign in Big Pharma by passing H.R. 1 and ensuring that Congress puts the public’s interests ahead of special interests.”

“In every corner of the First District I hear from Granite Staters about the significant burden and anxiety caused by the skyrocketing cost of prescription drugs,” said Congressman Pappas. “This is simply unacceptable at a time when drug companies are bringing in record breaking profits and using those profits to influence legislation aimed at lowering drug prices for Granite Staters. We must act now.”

"The For the People Act is the key to making government work for people, not just mega-donors and special interests,” said ECU Action Fund President Tiffany Muller. “H.R. 1 passed the House earlier this spring with unanimous support of House Democrats but has since been buried in Mitch McConnell’s graveyard. Progress can’t be made on lowering prescription drug prices until we get money out of politics. This begins with a vote on the For the People Act in the Senate.”

In addition to H.R. 1, Congressmen Pappas and Sarbanes have helped pass several bills to lower the cost of prescription drugs by ending Big Pharma tactics that prevent lower-cost generic drugs from going to market. Majority Leader McConnell continues to block these health care bills, along with H.R. 1, in the U.S. Senate.

###